Literature DB >> 12654749

Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance.

Stephanie A Chisholm1, Robert J Owen.   

Abstract

Metronidazole resistance in Helicobacter pylori reportedly occurs by mutational inactivation of the oxygen-insensitive nitroreductase gene rdxA. Nucleotide sequences of rdxA were determined in a set of 46 isolates from 19 dyspeptic patients from the UK. The study set comprised matched isolates that were either metronidazole susceptible (four) or mixed metronidazole susceptible and metronidazole resistant (15) before therapy and metronidazole resistant post-therapy (10) in the 11 patients that were followed up. Various mutation types were identified in rdxA of metronidazole-resistant strains (post-treatment) that were absent in matched metronidazole-susceptible strains (pre-treatment). However, rdxA sequences from pre-treatment metronidazole-resistant and metronidazole-susceptible subpopulations were identical in 11 of 15 patients. Thus, mutations in rdxA may not always be essential for metronidazole resistance. Future examination of rdxA expression at the transcription and translational level may provide further insight into the role of this locus in metronidazole action and resistance in H. pylori.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654749     DOI: 10.1093/jac/dkg192

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

Review 3.  Optimal therapy for Helicobacter pylori infections.

Authors:  Emiko Rimbara; Lori A Fischbach; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

4.  Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.

Authors:  Mohsen Karbalaei; Amin Talebi Bezmin Abadi; Masoud Keikha
Journal:  BMC Infect Dis       Date:  2022-06-25       Impact factor: 3.667

Review 5.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 6.  High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.

Authors:  Mei Zhang
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

7.  Screening for metronidazole-resistance associated gene fragments of H pylori by suppression subtractive hybridization.

Authors:  Ai-Qing Li; Ning Dai; Jie Yan; Yong-Liang Zhu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

8.  Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.

Authors:  Ousman Secka; Douglas E Berg; Martin Antonio; Tumani Corrah; Mary Tapgun; Robert Walton; Vivat Thomas; Juan J Galano; Javier Sancho; Richard A Adegbola; Julian E Thomas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

9.  The Bioinformatics Report of Mutation Outcome on NADPH Flavin Oxidoreductase Protein Sequence in Clinical Isolates of H. pylori.

Authors:  Nasrin Mirzaei; Farkhondeh Poursina; Sharareh Moghim; Abdol Majid Ghaempanah; Hajieh Ghasemian Safaei
Journal:  Curr Microbiol       Date:  2016-01-28       Impact factor: 2.188

10.  Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario.

Authors:  Nelson F Eng; Gustavo Ybazeta; Katrina Chapman; Nya L Fraleigh; Rebecca Letto; Eleonora Altman; Francisco Diaz-Mitoma
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.